J. A.
Vázquez de Prada
Publications by the researcher in collaboration with J. A. Vázquez de Prada (16)
2024
-
Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313
2022
-
Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes
Revista Espanola de Cardiologia, Vol. 75, Núm. 2, pp. 129-140
2021
-
Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970
2020
-
Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 919-926
2015
-
First report of the Spanish Post-Heart-Transplant Tumor Registry
Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 50-57
-
Registro Español de Trasplante Cardiaco (Adultos). XXV Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2013)
Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 31-42
2014
-
Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?
International Journal of Cardiology, Vol. 171, Núm. 1, pp. 15-23
2013
-
Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation
Clinical Transplantation, Vol. 27, Núm. 6
2012
-
Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation
Journal of Heart and Lung Transplantation, Vol. 31, Núm. 3, pp. 288-295
2011
-
Risk factors associated with cytomegalovirus infection in heart transplant patients: A prospective, epidemiological study
Transplant Infectious Disease, Vol. 13, Núm. 2, pp. 136-144
2010
-
Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: Results from the CAPRI study
Clinical Transplantation, Vol. 24, Núm. 4
-
Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: Results from the CAPRI study
Clinical Transplantation, Vol. 24, Núm. 5, pp. 194-200
-
Temporal trends in the use of proliferation signal inhibitors in maintenance heart transplantation: A Spanish multicenter study
Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2997-3000
2009
-
Steroid Use in Heart Transplant Patients in Spain in the Current Era: A Multicenter Survey
Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2244-2246
2008
-
Malignancy after heart transplantation: Incidence, prognosis and risk factors
American Journal of Transplantation, Vol. 8, Núm. 5, pp. 1031-1039
2007
-
Influence of Induction Therapy, Immunosuppressive Regimen and Anti-viral Prophylaxis on Development of Lymphomas After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumour Registry
Journal of Heart and Lung Transplantation, Vol. 26, Núm. 11, pp. 1105-1109